Citi Pharma Ltd. Announces Moderate Growth Amid Market Volatility

Islamabad, Citi Pharma Ltd. (CPHL) announced moderate growth amidst market volatility at the Pakistan Stock Exchange (PSE). With a daily weighted average rate of Rs. 2,284.61, the pharmaceutical company continues to navigate through challenging market conditions. CPHL, listed since 2021, reported an EPS of Rs. 2.88 for the year 2022/2023, reflecting its steady performance in the sector. The company, with a paid-up capital of Rs. 27.26 million, did not declare any distributions for the year ending June. Despite market fluctuations, Citi Pharma remains resilient, with a book closure on October 20th and a market lot of 10 shares.